Abstract:Background: Obesity is accompanied by excess adipose fat storage, which may lead to adipose dysfunction, insulin resistance, and type 2 diabetes (T2D). Currently, the tendency to develop T2D in obesity cannot be explained by genetic variation alone-epigenetic mechanisms, such as DNA methylation, might be involved. Here, we aimed to identify changes in DNA methylation and gene expression in visceral adipose tissue (VAT) that might underlie T2D susceptibility in patients with obesity. Methods: We investigated DNA methylation and gene expression in VAT biopsies from 19 women with obesity, without (OND = 9) or with T2D (OD = 10). Differences in genome-scale methylation (differentially methylated CpGs [DMCs], false discovery rate < 0.05; and differentially methylated regions [DMRs], p value < 0.05) and gene expression (DEGs, p value <0.05) between groups were assessed. We searched for overlap between altered methylation and expression and the impact of altered DNA methylation on gene expression, using bootstrap Pearson correlation. The relationship of altered DNA methylation to T2D-related traits was also tested. Results: We identified 11 120 DMCs and 96 DMRs distributed across all chromosomes, with the greatest density of epigenomic alterations at the MHC locus. These alterations were found in newly and previously T2D-related genes. Several of these findings were supported by validation and extended multi-ethnic analyses. Of 252 DEGs in the OD group, 68 genes contained DMCs (n = 88), of which 24 demonstrated a significant relationship between gene expression and methylation (p values <0.05). Of these, 16, including ATP11A, LPL and EHD2 also showed a significant correlation with fasting glucose and HbA1c levels. Conclusions: Our results revealed novel candidate genes related to T2D pathogenesis in obesity. These genes show perturbations in DNA methylation and expression profiles in patients with obesity and diabetes. Methylation profiles were able to discriminate OND from OD individuals; DNA methylation is thus a potential biomarker.

Differential DNA Methylation Status Between Human Preadipocytes and Mature Adipocytes

Genome-wide Methylation Dynamics and Context-dependent Gene Expression Variability in Differentiating Preadipocytes

DNA Methylation and Adipose Tissue Development

Regulation of Adipocyte Differentiation by DNA Methylation

WGBS of Differentiating Adipocytes Reveals Variations in DMRs and Context-Dependent Gene Expression

Alterations of DNA methylation profile in peripheral blood of children with simple obesity

Genome‐wide Analysis Reveals That Altered Methylation in Specific CpG Loci is Associated with Childhood Obesity

Metaboepigenetic regulation of gene expression in obesity and insulin resistance

Obesity related methylation changes in DNA of peripheral blood leukocytes

Epigenetic regulation of adipose tissue expansion and adipogenesis by<i>N</i><SUP>6</SUP>-methyladenosine

Global Analysis of DNA Methylation Variation in Adipose Tissue from Twins Reveals Links to Disease-Associated Variants in Distal Regulatory Elements

Co-Methylated Genes In Different Adipose Depots Of Pig Are Associated With Metabolic, Inflammatory And Immune Processes

DNA Microarray Analysis of Genes Differentially Expressed in Adipocyte Differentiation

Maternal obesity alters methylation level of cytosine in CpG island for epigenetic inheritance in fetal umbilical cord blood

Epigenetic regulation of diabetogenic adipose morphology

Novel Differentially Methylated Regions Identified by Genome-Wide DNA Methylation Analyses Contribute to Racial Disparities in Childhood Obesity

Nutrition, DNA methylation and obesity across life stages and generations

Obesity-Associated Differentially Methylated Regions in Colon Cancer

DNA methylation and gene expression analysis in adipose tissue to identify new loci associated with T2D development in obesity

An Atlas of DNA Methylomes in Porcine Adipose and Muscle Tissues